Abstract:Objectives: Previous work in our laboratory has shown that α-adrenoreceptors (α-ARs) and β-ARs exist on lymphocytes from functional profile, and that the receptors mediate the regulation of lymphocyte function by catecholamines. In the present study, we directly examined the expression of α-AR subtypes, α1-AR and α2-AR mRNAs, in T lymphocytes and explored the roles of the α-AR subtypes and intracellular signal transduction mechanisms linked to the receptors in mediating the modulation of T lymphocyte function. Methods: T lymphocytes from mesenteric lymph nodes of rats were purified by using a nylon wool column. Reverse transcription polymerase chain reaction was used to detect the expression of α1-AR and α2-AR mRNAs in the freshly isolated T cells and the mitogen concanavalin A (Con A)-activated lymphocytes. Colorimetric methylthiazoletetrazolium assay was employed to measure lymphocyte proliferation induced by Con A. Interferon-γ (IFN-γ) and interleukin-4 (IL-4) levels in the Con A-stimulated lymphocyte culture supernatants were examined by enzyme-linked immunosorbent assay. Results: T cells expressed both α1-AR and α2-AR mRNAs. The expression of both α1-AR and α2-AR mRNAs was significantly higher in the Con A-activated lymphocytes than in the resting lymphocytes. Phenylephrine, a selective α1-AR agonist, had no evident effect on lymphocyte proliferation nor on IFN-γ and IL-4 production induced by Con A. However, the selective α2-AR agonist clonidine attenuated Con A-induced lymphocyte proliferation as well as IFN-γ and IL-4 production. The inhibited lymphocyte proliferation and IFN-γ and IL-4 production by clonidine were blocked by yohimbine, an α2-AR antagonist. Either phospholipase C inhibitor U-73122 or protein kinase C inhibitor chelerythrine partially prevented the suppressive effect of clonidine on Con A-stimulated lymphocyte proliferation and IL-4 production. Conclusions: T lymphocytes express both α1-ARs and α2-ARs, but only the α2-ARs participate in the suppressive modulation of lymphocyte proliferation and cytokine production in vitro. The inhibitory effect of α2-AR stimulation on lymphocyte function is partially mediated via the phospholipase C-protein kinase C pathway.

Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism

ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor.

Identification Of Distinct Carboxyl-Terminal Domains Mediating Internalization And Down-Regulation Of The Hamster Alpha(1b) Adrenergic Receptor

[Effect of Alpha 1-Adrenoceptor Subtypes on Beta-Adrenoceptor Mediated Positive Inotropic Response in Rat Left Atria].

Alpha(1)-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart

Single Amino Acid of an Octopamine Receptor As a Molecular Switch for Distinct G Protein Couplings

A mutation in the hamster alpha(1B)-adrenergic receptor that differentiates two steps in the pathway of receptor internalization

Different conformational responses of the <sub>2</sub>-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

[Antagonistic Characterization of 1-(2,6-dimethylphenoxyl)-2-(3,4-dimethylphenyl Ethylamino) Propane Hydrochloride on Alpha 1-Adrenoceptor].

A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Tyrosine 308 is Necessary for Ligand-directed Gs Protein-biased Signaling of Β2-Adrenoceptor

The Discovery of Novel α2a Adrenergic Receptor Agonists Only Coupling to Gαi/O Proteins by Virtual Screening

Allosterism in the adenosine A2A and cannabinoid CB2 heteromer

Control of conformational equilibria in the human B2 bradykinin receptor. Modeling of nonpeptidic ligand action and comparison to the rhodopsin structure

Species differences and mechanism of action of A3 adenosine receptor allosteric modulators

Mechanism of Β 2 AR Regulation by an Intracellular Positive Allosteric Modulator

Different conformational responses of the β2-adrenergic receptor-Gs complex upon binding of the partial agonist salbutamol or the full agonist isoprenaline

Functionally biased modulation of A3 adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers

Amiloride Derivatives and a Nonpeptidic Antagonist Bind at Two Distinct Allosteric Sites in the Human Gonadotropin-Releasing Hormone Receptor

Expression of Alpha-Ar Subtypes in T Lymphocytes and Role of the Alpha-Ars in Mediating Modulation of T Cell Function

Subtypes Optimizes -Adrenergic Modulation of Cardiac Contractility